Related Experiment Video
Updated: May 8, 2026
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Chemotherapy-related cognitive dysfunction: current animal studies and future directions.
R Seigers1, S B Schagen, O Van Tellingen
1Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands, R.seigers@nki.nl.
Brain Imaging and Behavior
|August 17, 2013
Summary
Chemotherapy can cause long-term cognitive impairment in cancer survivors. This review summarizes preclinical research on chemotherapy-induced neurotoxicity, focusing on protective strategies and the blood-brain barrier.
Area of Science:
- Neuroscience
- Oncology
- Pharmacology
Background:
- Adjuvant chemotherapy can lead to long-term cognitive impairment, significantly impacting cancer survivors' quality of life.
- Chemotherapy-induced neurotoxicity is a growing concern, with increasing preclinical research investigating its underlying mechanisms.
Purpose of the Study:
- To review recent advances in preclinical studies on chemotherapy-induced neurotoxicity.
- To discuss emerging challenges, including neuroprotective strategies and the blood-brain barrier's role in cognitive impairment.
- To outline future research directions in this field.
Main Methods:
- Systematic review of preclinical studies on chemotherapy and cognitive function.
- Analysis of research on neurotoxicity mechanisms.
- Evaluation of studies on neuroprotective interventions and blood-brain barrier function.
Main Results:
- Preclinical studies are expanding the understanding of chemotherapy's impact on cognitive function.
- Key mechanisms of chemotherapy-induced neurotoxicity are being elucidated.
- Research highlights the potential role of the blood-brain barrier in cognitive deficits.
Conclusions:
- Further research into neuroprotective strategies is crucial for mitigating chemotherapy-induced cognitive impairment.
- Understanding the blood-brain barrier is essential for developing effective interventions.
- Continued investigation into chemotherapy's long-term neurological side effects is warranted.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...